Explore All 3111 Add-on Acquisition Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | May 31, 2017 |
| Target | Integrated Development Associates Co. |
| Sector | Life Science |
| Buyer(s) | Chiltern International |
| Deal Type | Add-on Acquisition |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1999 |
| Sector | Life Science |
Chiltern International, Inc. is a global contract research organization, and a provider of clinical services and solutions in a variety of therapeutic areas with engagement models for biopharmaceutical and medical device industries. Chiltern’s team of more than 4,500, located across 47 countries, provides comprehensive Clinical Development, Medical & Scientific Affairs, Data & Analysis, Pharmacovigilance and Strategic Regulatory services using a collaborative approach for more efficient clinical trials. Visit Chiltern.com to learn more about how Chiltern is Designed Around You®.
| Deal Context for Buyer | # |
|---|---|
| Overall | 4 of 4 |
| Sector: Life Science | 4 of 4 |
| Type: Add-on Acquisition | 4 of 4 |
| Country: Japan | 1 of 1 |
| Year: 2017 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-08-06 |
Theorem Clinical Research Holdings
King of Prussia, Pennsylvania, United States Theorem Clinical Research Holdings LLC is a full-service, global clinical research organization. Theorem Clinical Research conducts early phase, phase II/III and late phase clinical trials for the pharmaceutical, biotechnology and medical device industries. The Company also provides technical services that support clinical trials, with a particular focus on data management and biostatistics services. |
Buy | - |
